Shire News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

28.11.16	Drug Makers Stocks on Investors' Radar -- Immune Pharma, Sanofi, Biostar Pharma, and Shire (PR Newswire)
22.11.16	Shire to Establish Rare Disease Innovation Hub in Cambridge, Mass. (PR Newswire)
16.11.16	Shire Launches Cuvitru In U.S. For Primary Immunodeficiency - Quick Facts (RTTNews)
01.11.16	Shire Q3 Profit Misses Estimates; Product Sales Up 12% Excl. Baxalta (RTTNews)
27.10.16	Shire Presents Data From Phase 2 Study Evaluating Maribavir (RTTNews)
17.10.16	Shire Updates Vyvanse U.S. Labeling To Include New Efficacy Data - Quick Facts (RTTNews)
06.10.16	Kamada To Produce GLASSIA For Shire Through 2020 - Quick Facts (RTTNews)
06.10.16	Patent Trial And Appeal Board Upholds Validity Of Shire's LIALDA Patent (RTTNews)
28.09.16	GALT In A Fix, SHPG Ends Biosimilar Deals, KTOV Moves Closer To File KIT-302 NDA (RTTNews)
20.09.16	Shire Prices Public Offering Of Senior Notes - Quick Facts (RTTNews)
15.09.16	Data Boosts AERI, FDA Panel Snubs SPPI, D-Day For ACRX Today, VTAE Abuzz (RTTNews)
14.09.16	Shire Gets FDA Approval For Cuvitru To Treat Immunodeficiency (RTTNews)
02.08.16	Shire Plc Q2 Profit Tops Estimates; Updates 2016 Guidance (RTTNews)
01.08.16	Shire : FDA Approves BAXJECT III Reconstitution System For ADYNOVATE (RTTNews)
01.08.16	TKAI Laying Off Staff Big Time, MCRB Plunges, FDA Says No To ADMA (RTTNews)
21.07.16	Shire Launches Pediatric Indication For HyQvia In Europe - Quick Facts (RTTNews)
12.07.16	CYTR Plunges, FDA Nod For AMGN, Shire, SCMP Gives Up On Cobiprostone (RTTNews)
12.07.16	FDA Approves Shire's Xiidra To Treat Signs And Symptoms Of Dry Eye Disease (RTTNews)
07.07.16	Shire Receives Extension Of Market Authorization In Europe For Revestive (RTTNews)
01.07.16	It's A Ten For Humira, AMPE Drubbed By PIVOT Data, CYNA Awaits Data In Q3 (RTTNews)
30.06.16	Shire: SHP607 Trial Shows Positive Secondary Endpoints Related To Lung, Brain (RTTNews)
30.06.16	Biotech Stocks Facing FDA Decision In July (RTTNews)
29.06.16	Shire Reports Positive Topline Results From SHP465 Study - Quick Facts (RTTNews)
15.06.16	Shire, Kamada: FDA Approves Expanded Label For Self-infusion Of GLASSIA (RTTNews)
15.06.16	CHMA Trims Workforce, INFI's DYNAMO Disappoints, Marathon Joins DMD Race (RTTNews)
14.06.16	Shire To License IBD Drug PF-00547659 From Pfizer; Terms Not Disclosed (RTTNews)
13.06.16	Shire Gets FDA Breakthrough Therapy Designation For 2 Products For Rare Diseases (RTTNews)
03.06.16	Shire Completes Combination With Baxalta - Quick Facts (RTTNews)
27.05.16	Baxalta Announces Shareholder Approval For Merger Deal With Shire - Quick Facts (RTTNews)
29.04.16	Shire Reiterates 2016 Outlook - Quick Facts (RTTNews)
28.04.16	Baxalta Q1 Profit Down On Charges, Revenues Up - Quick Facts (RTTNews)
15.04.16	D-Day Awaits CHMA, APHB Abandons XON Collaboration, More On The Way For Opdivo (RTTNews)
07.04.16	Shire Says Proposed Merger With Baxalta On Track To Close In Mid-2016 (RTTNews)
05.04.16	CYTR Awaits Data In June, GILD Gets FDA Nod, PGNX Will Have To Wait (RTTNews)
04.04.16	Shire Reports Positive Topline Results From SHP465-305 Study - Quick Facts (RTTNews)
16.02.16	Baxalta To Not Host Investor Conference And Update 2016 Guidance - Quick Facts (RTTNews)
11.02.16	Shire Full Year 2015 Profit Declines; Announces 2016 Outlook (RTTNews)
05.02.16	SCLN Settles FCPA Charges, OGXI On Cost Discipline Mode, Shire To Face FDA (RTTNews)
26.01.16	AMGN Gets FDA Date, PETX On The Move, CTIX Awaits Data In Q2, SHPG Makes 2nd Try (RTTNews)
25.01.16	Shire Resubmits New Drug Application For Lifitegrast To FDA - Quick Facts (RTTNews)
22.01.16	Shire Plc Completes Acquisition Of Dyax - Quick Facts (RTTNews)
11.01.16	Shire To Combine With Baxalta In $32 Bln Cash And Stock Deal (RTTNews)
03.01.16	Shire In Advanced Talks To Buy Baxalta: Bloomberg (RTTNews)
04.12.15	Shire Appoints Directors To Board Committees - Quick Facts (RTTNews)
03.12.15	Dyax Gets U.S. Regulatory Approval For Acquisition By Shire (RTTNews)
03.11.15	ACAD Gets FDA Date, Insight On BIND, Mega Deals Of Monday, PRTA On Track (RTTNews)
02.11.15	Shire To Acquire Dyax In $5.9 Bln Cash Deal (RTTNews)
27.10.15	Shire Plc: OPUS-3 Phase 3 Trial With Lifitegrast Meets Primary Endpoint (RTTNews)
23.10.15	Shire Q3 Results Beat Estimates, Reiterates FY15 EPS Outlook (RTTNews)
13.10.15	Shire: CINRYZE Receives FDA Fast Track Designation - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Shire plc (Spons. ADRs)

Aktien Top/Flop

Meistgelesene Nachrichten